Pathogenic effector functions of ACPA: Where do we stand?
Publication
, Journal Article
Toes, R; Pisetsky, DS
Published in: Ann Rheum Dis
June 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Rheum Dis
DOI
EISSN
1468-2060
Publication Date
June 2019
Volume
78
Issue
6
Start / End Page
716 / 721
Location
England
Related Subject Headings
- Humans
- Chemokines
- Autoantibodies
- Arthritis, Rheumatoid
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Toes, R., & Pisetsky, D. S. (2019). Pathogenic effector functions of ACPA: Where do we stand? Ann Rheum Dis, 78(6), 716–721. https://doi.org/10.1136/annrheumdis-2019-215337
Toes, René, and David S. Pisetsky. “Pathogenic effector functions of ACPA: Where do we stand?” Ann Rheum Dis 78, no. 6 (June 2019): 716–21. https://doi.org/10.1136/annrheumdis-2019-215337.
Toes R, Pisetsky DS. Pathogenic effector functions of ACPA: Where do we stand? Ann Rheum Dis. 2019 Jun;78(6):716–21.
Toes, René, and David S. Pisetsky. “Pathogenic effector functions of ACPA: Where do we stand?” Ann Rheum Dis, vol. 78, no. 6, June 2019, pp. 716–21. Pubmed, doi:10.1136/annrheumdis-2019-215337.
Toes R, Pisetsky DS. Pathogenic effector functions of ACPA: Where do we stand? Ann Rheum Dis. 2019 Jun;78(6):716–721.
Published In
Ann Rheum Dis
DOI
EISSN
1468-2060
Publication Date
June 2019
Volume
78
Issue
6
Start / End Page
716 / 721
Location
England
Related Subject Headings
- Humans
- Chemokines
- Autoantibodies
- Arthritis, Rheumatoid
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences